Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Informed consent: communicating drug risks to patients

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Informed consent: communicating drug risks to patients. React. Wkly. 765, 2 (1999). https://doi.org/10.2165/00128415-199907650-00001

    Download citation

    Keywords

    • Thalidomide
    • American Medical Association
    • Pharmaceutical Manufacturer
    • Isotretinoin
    • Regulate Product